03:28 AM EST, 01/21/2026 (MT Newswires) -- Justin B. Klee, Director, Co-Chief Executive Officer, on January 15, 2026, sold 138,188 shares in Amylyx Pharmaceuticals ( AMLX ) for $1,877,570. Following the Form 4 filing with the SEC, Klee has control over a total of 3,379,398 common shares of the company, with 3,379,398 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1658551/000119312526017056/xslF345X05/ownership.xml